ea0049ep603 | Diabetes therapy | ECE2017
de Linares Lidia Urbon Lopez
, Soto Cristina Crespo
, Terroba Concepcion
, Garrote Sara
, Ventosa Marta
, Marin Tomas
, Cuellar Luis
In the late years ISGLT2 have became an usual choice to treat diabetes. The inhibition of the sodium-glucose co transporters (SLGT2) inhibits also the glucose reabsorption in the proximale tubule and increases the glucose excreted in the urine. Therefore hyperglycemia decreases and so does weight. This is a very convenient side effect since type 2 DM is highly associated with overweight/obesity. We show the results of HbA1c and weight evolution after starting canaglifozina 100...